Nucleonics
Founded Year
2001Stage
Series B | AliveTotal Raised
$50.8MLast Raised
$49.2M | 19 yrs agoAbout Nucleonics
Nucleonics is developing a method of RNA interference to silence disease-causing genes. Initially, the company is applying its technology to develop expressed interfering RNA (eiRNA) therapies for the treatment of chronic Hepatitis B and Hepatitis C viral infections.
Missing: Nucleonics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Nucleonics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Nucleonics Patents
Nucleonics has filed 1 patent.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
4/22/2004 | 5/5/2009 | Transcription factors, Molecular biology, Gene expression, Human proteins, Biotechnology | Grant |
Application Date | 4/22/2004 |
---|---|
Grant Date | 5/5/2009 |
Title | |
Related Topics | Transcription factors, Molecular biology, Gene expression, Human proteins, Biotechnology |
Status | Grant |
Latest Nucleonics News
Oct 21, 2022
https://www.everythingrf.com/news/details/15289-berkeley-nucleonics-corporation-to-showcase-their-latest-rf-microwave-t-m-equipment-at-aoc-2022 October 21, 2022 | Editorial Team Berkeley Nucleonics Corporation , a leading electronic instrumentation manufacturer, will attend the 59th Annual AOC International Symposium and Convention in Washington, DC, on October 25-27, 2022. The experienced San Rafael team will be in attendance throughout the entire event, meeting with attendees to discuss their current projects and applications and how BNC can help. Visitors attending the 59th annual AOC International Symposium and Convention will be able to find the BNC team at Booth 607. Founded in 1963, the California-based company has become one of the global leaders in the manufacture of precision electronic instrumentation for testing and measurement, radiation detection, nuclear research, and RF/microwave. At the symposium, they will showcase their innovative array of cutting-edge signal sources, phase noise testers, and other test and measurement equipment. Speaking ahead of the event, Allan Gonzalez, Vice President at Berkeley Nucleonics Corporation added, “We are really excited to be heading to the 2022 AOC International Symposium and Convention. It is one of the biggest events in our industry and is a fantastic opportunity for our team to meet with both military and government professionals, as well as allow them to learn more about our extensive range of products. Our experienced team is going to be in attendance throughout the three days, and we are really looking forward to meeting as many attendees as possible.” Considered the premier event for electronic warfare, electromagnetic spectrum operations, cyber-electromagnetic activities, and information operations professionals, the annual AOC International Symposium and Convention will welcome over 2,000 industry, military, and government individuals over the three days.
Nucleonics Frequently Asked Questions (FAQ)
When was Nucleonics founded?
Nucleonics was founded in 2001.
Where is Nucleonics's headquarters?
Nucleonics's headquarters is located at 13 Summit Square Center, Langhorne.
What is Nucleonics's latest funding round?
Nucleonics's latest funding round is Series B.
How much did Nucleonics raise?
Nucleonics raised a total of $50.8M.
Who are the investors of Nucleonics?
Investors of Nucleonics include SR One, New Enterprise Associates, Anthem Capital, Burrill & Company, POSCO Capital and 6 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.